Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas

[1] Tantai N(2014)A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand BMC Health Serv Res 14 170-225

[2] Chaikledkaew U(2019)Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in colorectal cancer patients J Gastrointest Cancerd 12 35-1405

[3] Tanwandee T(2014)Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma Health Qual Life Outcomes 11 215-210

[4] Ameri H(2010)A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Heal Econ Prev Care 21 1399-10

[5] Yousefi M(2018)Mapping the FACT-B instrument to EQ-5D-3L in patients with breast cancer using adjusted limited dependent variable mixture models versus response mapping Value Heal 16 202-139

[6] Yaseri M(2015)Mapping functions in health-related quality of life : mapping from two quality-of-life instruments to EQ-5D-3L Med Decis Mak 16 1-1736

[7] Proskorovsky I(2013)Mapping to obtain EQ-5D utility values for use in NICE health technology assessments Value Heal 94 135-765

[8] Lewis P(2016)The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study BMC Health Serv Res 20 1727-568

[9] Williams C(2001)The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample Int J cancer 13 753-669

[10] Brazier J(2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res 32 554-239

[1] Tantai N(2014)A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand BMC Health Serv Res 14 170-225

[2] Chaikledkaew U(2019)Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in colorectal cancer patients J Gastrointest Cancerd 12 35-1405

[3] Tanwandee T(2014)Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma Health Qual Life Outcomes 11 215-210

[4] Ameri H(2010)A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Heal Econ Prev Care 21 1399-10

[5] Yousefi M(2018)Mapping the FACT-B instrument to EQ-5D-3L in patients with breast cancer using adjusted limited dependent variable mixture models versus response mapping Value Heal 16 202-139

[6] Yaseri M(2015)Mapping functions in health-related quality of life : mapping from two quality-of-life instruments to EQ-5D-3L Med Decis Mak 16 1-1736

[7] Proskorovsky I(2013)Mapping to obtain EQ-5D utility values for use in NICE health technology assessments Value Heal 94 135-765

[8] Lewis P(2016)The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study BMC Health Serv Res 20 1727-568

[9] Williams C(2001)The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample Int J cancer 13 753-669

[10] Brazier J(2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res 32 554-239